Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes

Journal of Virology

Volumn 71, Issue 6, 1997, Pages 4226-4232

  Anderson, Robert ^a   Wang, Songli ^a   Osiowy, Carla ^a,b   Issekutz, Andrew C ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b HEALTH CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1; VIRUS ANTIBODY;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INOCULATION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; UMBILICAL VEIN; VERO CELL; VIRUS IMMUNITY;

EID: 0030912593     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.6.4226-4232.1997     Document Type: Article

References (51)

1. Aarli, A., R. Matre, and S. Thunold. 1991. IgG Fc receptors on epithelial cells of distal tubuli and on endothelial cells in human kidney. Int. Arch. Allergy Appl. Immunol. 95:64-69.
2. Andrews, B. S., A. N. Theofilopoulos, C. J. Peters, D. J. Loskutoff, W. E. Brandt, and F. J. Dixon. 1978. Replication of dengue and junin viruses in cultured rabbit and human endothelial cells. Infect. Immun. 20:776-781.
3. Beutler, B., and G. E. Gau. 1993. Tumor necrosis factor in the pathogenesis of infectious diseases. Crit. Care Med. 21:S423-S435.
4. Bevilacqua, M. P. 1993. Endothelial-leukocyte adhesion molecules. Annu. Rev. Immunol. 11:767-804.
5. Brandt, W. E., J. M. McCown, M. K. Gentry, and P. K. Russell. 1982. Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infect. Immun. 36:1036-1041.
6. Brandt, W. E., J. M. McCown, F. H. Top, W. H. Bancroft, and P. K. Russell. 1979. Effect of passage history on dengue-2 virus replication in subpopulations of human leukocytes. Infect. Immun. 26:534-541.
7. Braquet, P., L. Touqui, T. Y. Shen, and B. B. Vargaftig. 1987. Perspectives in platelet activating factor research. Pharmacol. Rev. 39:97-145.
8. Carlos, T. M., and J. M. Harlan. 1994. Leukocyte-endothelial adhesion molecules. Blood 84:2068-2101.
9. Cosgriff, T. M. 1989. Viruses and hemostasis. Rev. Infect. Dis. 2:S672-S688.
10. Daughaday, C. C., W. E. Brandt, J. M. McCown, and P. K. Russell. 1981. Evidence for two mechanisms of dengue virus infection of adherent human monocytes: trypsin-sensitive virus receptors and trypsin-resistant immune complex receptors. Infect. Immun. 32:469-473.
11. Dinarello, C. A. 1991. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J. Infect. Dis. 163:1177-1184.
12. Fisher-Hoch, S. P., G. S. Platt, G. H. Neild, T. Southee, A. Baskerville, R. T. Raymond, G. Lloyd, and D. I. H. Simpson. 1985. Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola). J. Infect. Dis. 152:887-894.
13. Giminez, H. B., H. M. Keir, and P. Cash. 1989. In vitro enhancement of respiratory syncytial virus infection of U937 cells by human sera. J. Gen. Virol. 70:89-96.
14. Gras, G., T. Strub, and D. Dormont. 1988. Antibody-dependent enhancement of HIV infection. Lancet 1:1285.
15. Halstead, S. B. 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239:476-481.
16. Halstead, S. B. 1989. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev. Infect. Dis. 11(Suppl. 4): S830-S839.
17. Halstead, S. B. 1990. Dengue, p. 675-685. In K. S. Warren and A. A. F. Mahmoud (ed.), Tropical and geographical medicine. McGraw-Hill, New York, N.Y.
18. Halstead, S. B., and E. J. O'Rourke. 1977. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J. Exp. Med. 146:201-218.
19. Halstead, S. B., J. S. Porterfield, and E. J. O'Rourke. 1980. Enhancement of dengue virus infection in monocytes by flavivirus antisera. Am. J. Trop. Med. Hyg. 29:638-642.
20. Halstead, S. B., and P. Simasthien. 1970. Observations related to pathogenesis of dengue hemorrhagic fever. II. Antigenic and biologic properties of dengue viruses and their association with disease responses in the host. Yale J. Biol. Med. 42:276-292.
21. He, R. T., B. L. Innis, A. Nisalak, W. Usawattanakul, S. Wang, S. Kalayanarooj, and R. Anderson. 1995. Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2. J. Med. Virol. 45:451-161.
22. Hober, D., L. Poli, B. Roblin, P. Gestas, E. Chungue, G. Granic, P. Imbert, J. L. Pecarere, R. Vergez-Pascal, P. Wattre, and M. Maniez-Montreuil. 1993. Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and interleukin-1 beta (IL-1 beta) in dengue-infected patients. Am. J. Trop. Med. Hyg. 48:324-331.
23. Hofman, F. M., A. D. Wright, M. M. Dohadwala, F. Wong-Staal, and S. M. Walker. 1993. Exogenous tat protein activates human endothelial cells. Blood 82:2774-2780.
24. Homsy, J., M. Tatero, and J. A. Levy. 1988. Antibody-dependent enhancement of HIV infection. Lancet 1:1285-1286.
25. Innis, B. L., A. Nisalak, S. Nimmannitya, S. Kusalerdchariya, V. Chongswasdi, S. Suntayakorn, P. Puttisri, and C. H. Hoke. 1989. An enzyme-linked immunoadsorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am. J. Trop. Med. Hyg. 40:418-427.
26. Issekutz, A. C., and N. Lopes. 1993. Endotoxin activation of endothelium for polymorphonuclear leukocyte transendothelial migration and modulation by interferon-gamma. Immunology 79:600-607.
27. Jaffe, E. A., R. L. Nachman, C. G. Becker, and C. R. Minick. 1973. Culture of human endothelial cells derived from umbilical veins. Identification by morphological and immunologic criteria. J. Clin. Invest. 52:2745-2752.
28. Jirik, F. R., T. J. Podor, T. Hirano, T. Kishimoto, D. J. Loskutoff, D. A. Carson, and M. Lotz. 1989. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J. Immunol. 142:144-147.
29. Joubert, J. R., J. B. King, D. J. Rossouw, and R. Cooper. 1985. A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg hospital. III. Clinical pathology and pathogenesis. S. Afr. Med. J. 68:722-728.
30. Killen, H., and M. A. O'Sullivan. 1993. Detection of dengue virus by in situ hybridization. J. Virol. Methods 41:135-146.
31. Kliks, S. C., S. Nimmanitya, A. Nisalak, and D. S. Burke. 1988. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am. J. Trop. Med. Hyg. 38:411-419.
32. Kliks, S. C., A. Nisalak, W. E. Brandt, L. Wahl, and D. S. Burke. 1989. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 40:444-451.
33. Krilov, L. R., L. J. Anderson, L. Marcoux, V. R. Bonagura, and J. F. Wedgwood. 1989. Antibody-mediated enhancement of respiratory syncytial virus infection in two monocyte/macrophage cell lines. J. Infect. Dis. 160:777-782.
34. Kurane, I., A. L. Rothman, P. G. Livingston, S. Green, S. J. Gagnon, J. Janus, B. L. Innis, S. Nimmannitya, A. Nisalak, and F. A. Ennis. 1994. Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch. Virol. 136(Suppl. 9):59-64.
35. Lefer, A. M. 1989. Trends in shock research. Significance of lipid mediators in shock states. Circ. Shock 27:3-12.
36. Mauro, N., I. Morita, M. Shirao, and S. I. Murota. 1992. IL-6 increases endothelial permeability in vitro. Endocrinology 131:710.
37. Meltzer, M. S., D. L. Skillman, D. L. Hoover, B. D. Hanson, J. A. Turpin, D. C. Kalter, and H. E. Gendelman. 1990. Macrophages and the human immunodeficiency virus. Immunol. Today 11:217-223.
38. Morens, D. M., and S. B. Halstead. 1990. Measurement of antibody-dependent enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies. J. Gen. Virol. 71:2909-2914.
39. Nottet, H. S. L. M., and H. E. Gendelman. 1995. Unraveling the neuroimmune mechanisms for the HIV-1-associated cognitive/motor complex. Immunol. Today 16:441-448.
40. Ochiai, H., M. Kurokawa, K. Hayashi, and S. Niwayama. 1988. Antibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1. J. Virol. 62:20-26.
41. Osiowy, C., D. Home, and R. Anderson. 1994. Antibody-dependent enhancement of respiratory syncytial virus infection by sera from young infants. Clin. Diagn. Lab. Immunol. 1:670-677.
42. Peiris, J. S., S. Gordon, J. C. Unkeless, and J. S. Porterfield. 1981. Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages. Nature 289:189-191.
43. Robinson, W. E. J., D. C. Montefiori, and W. M. Mitchell. 1988. Antibody-dependent enhancement of human immunodeficiency virus type 1 infection. Lancet 1:790-794.
44. Rosenberg, Z. F., and A. S. Fauci. 1990. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol. Today 11: 176-180.
45. Schnittler, H.-J., F. Mahner, D. Drenckhahn, H.-D. Klenk, and H. Feldmann. 1993. Replication of Marburg virus in human endothelial cells. J. Clin. Invest. 91:1301-1309.
46. Sedmak, D. D., D. H. Davis, U. Singh, J. G. J. van de Winkel, and C. L. Anderson. 1991. Expression of IgG Fc receptor antigens in placenta and on endothelial cells in humans. Am. J. Pathol. 138:175-181.
47. Takeda, A., C. U. Tuazon, and F. A. Ennis. 1988. Antibody-enhanced infection of HIV-1 via Fc-receptor-mediated entry. Science 242:580-583.
48. Tamura, M., R. G. Webster, and F. A. Ennis. 1994. Subtype, cross-reactive, infection-enhancing antibody responses to influenza A viruses. J. Virol. 68: 3499-3504.
49. Vitarana, T., H. de Silva, N. Withana, and C. Gunasekera. 1991. Elevated tumour necrosis factor in dengue fever and dengue haemorrhagic fever. Ceylon Med. J. 36:63-65.
50. Whelan, J. 1996. Selectin synthesis and inflammation. Trends Biochem. Sci. 21:65-69.
51. Yadav, M., K. R. Kamath, N. Iyngkaran, and M. Sinniah. 1991. Dengue haemorrhagic fever and dengue shock syndrome: are they tumour necrosis factor-mediated disorders? FEMS Microbiol. Immunol. 89:45-50.